Hi all - I'm the wife of Ken, diagnosed in May 2020 with Stage 4, Gleason 9, extensive mets to bones, PSA 209. Started on Lupron, PSA dropped to 6 by mid August 2020. Traveled to Germany to St. Georg Klinik for insulin-potentiated chemo + full-body hyperthermia to complement ADT SOC treatments. CT and bone scans in the following October showed most mets resolved or decreasing. Started on Zytiga in December 2020. PSA continued to decline until reaching 0.2 in July 2021. Underwent radiation to the prostate to try and get one "residual tumor." Post-radiation PSA was 0.5 and doctors were very happy. Bloodwork was perfect. All numbers normal. MO wanted to wait until November 2021 for next PSA and CT/bone scans. PSA in November is all of a sudden 3.85, two weeks later, 6.25, two weeks later, 10.2. Bone scan is showing no new mets, mostly everything decreasing in size or resolved, but one problematic area on the pelvic bone increasing in size. CT scan is clear. No new areas of concern.
My question is - are we looking to do Xtandi next? Is it beneficial to do something in between Zytiga and Xtandi? Like Doxatacel or even BAT? Does BAT have a benefit for those with Gleason 9? The doubling time for PSA is so crazy that he'll be back up to his original numbers at diagnosis by May 2022. MO is already talking about clinical trials and it's really throwing us after such an amazing response to ADT at the beginning. Thanks to anyone who can tell me what questions to ask at the next appointment. He has no gene mutations that are helpful. He's 55 and we have 3 grade school-aged children.